Introduction
Make or break
The direction of the market and unsettled economic circumstances are changing the dynamics of success in digital health.
On the back of a pandemic-fuelled innovation and fundraising boom, the future outlook is more combative and complex – defined by competition for capital, regulatory scrutiny and fast cross-border expansion. Raising capital on sustainable terms, bringing effective products to market quickly and protecting competitive position are all increasingly critical to success, and increasingly challenging to achieve.
Digital health leaders need a new growth playbook that is built for this moment. This collection of ideas and experiences from digital health leaders and the Taylor Wessing experts who partner them explores how to grow through make or break moments.
Why read this playbook?
Benchmark...
your experiences, challenges and opportunities against 250 other digital health businesses.
Access...
insight from a community of innovators, investors and legal experts – covering capital raising, international expansion, the regulatory environment and more.
Discover...
the key principles of success in an increasingly complex and competitive digital health industry.
The topline
The next era of digital health is beginning. Innovators are responding to market saturation, changing competition and acute healthcare needs by building new, more complex and highly regulated products. But as companies move up the value chain and into unsettled economic conditions, they face new regulatory obstacles to growth and mounting pressure to deliver for investors.
The topline
The next era of digital health is beginning. Innovators are responding to market saturation, changing competition and acute healthcare needs by building new, more complex and highly regulated products. But as companies move up the value chain and into unsettled economic conditions, they face new regulatory obstacles to growth and mounting pressure to deliver for investors.
Next generation digital health
Initial digital health adoption was driven by consumer wellness products – app-based tools often designed to manage nutrition, physical activity and mental health. Today this market is saturated and competition has intensified across the digital health spectrum. As a result, an overwhelming majority of the digital health leaders we interviewed for this playbook see limited long-term growth potential in consumer wellness. But where next?
agree that long-term growth in the industry won't come from new wellness solutions.
say it is increasingly hard to compete with large retail and tech businesses in this space.
Moving up the value chain
We asked innovators what it takes to remain competitive and scale success in a changing market. The answer was clear.
They are moving up the value chain – capitalising on the digitisation of healthcare and new technology to solve bigger problems.
believe that to remain competitive they must develop products to solve more acute medical needs
Testing times
The path forward will test whether existing business models and strategies are ready to scale, particularly at a time when innovators anticipate new regulatory obstacles to growth and are under immense pressure from investors.
see new and changing regulation as a serious threat to their business model and value proposition.
say that investors have extraordinarily high expectations of growth and ROI.
How to break through
Despite the challenges involved with a changing market, opportunities abound for digital health innovators that can break through.
How to break through
Despite the challenges involved with a changing market, opportunities abound for digital health innovators that can break through.
Meet the contributors
Who are the innovators and experts that have shared their experiences in this playbook?
This playbook is a collection of insights from digital health leaders and the experts who partner them – representing the diversity of the digital health ecosystem.
Our capabilities
Our capabilities
Taylor Wessing helps digital health companies grow through make or break moments. We spot legal issues early that could compromise vision or value, support clients to weigh commercial decisions against regulatory limitations and propose simple solutions that overcome inherent industry complexity.
With decades spent advising leading pharmaceutical, biotech and medtech companies and fast growth businesses on a global scale, we understand the interplay of the law and commercial strategy. Bringing a growth mindset and deep sector knowledge to every instruction, Taylor Wessing is the law firm for digital health.
